NE Omaha의 전립선암 임상 시험
전립선암 관련 연구 29개가 Omaha 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
피험자 모집 중3상
- Alegent Health Bergan Mercy Medical Center, Omaha
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
피험자 모집 중2상
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9마일 거리
RYZ711 Diagnostic Platform Study
피험자 모집 중1/2상
- Research Facility, Omaha
WATER IV PCa (AS Sub-study)
피험자 모집 중
- Adult & Pediatric Urology, Omaha
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
피험자 모집 중2상
- XCancer Omaha, Omaha
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
피험자 모집 중1/2상
- Urology Cancer Center, PC, Omaha
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- XCancer, Omaha
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
피험자 모집 중3상
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9마일 거리
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
피험자 모집 중3상
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026), Omaha
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
피험자 모집 중2상
- University of Nebraska Medical Center, Omaha
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
피험자 모집 중3상
- Research Site, Omaha
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
피험자 모집 중1상
- Research Site, Omaha
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
피험자 모집 중3상
- Nebraska Cancer Specialists, Omaha
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
피험자 모집 중1/2상
- Research Site, Omaha
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
피험자 모집 중3상
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- 외 1개
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
피험자 모집 중2/3상
- Nebraska Cancer Specialists, Omaha
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
피험자 모집 중2상
- University of Nebraska Medical Center, Omaha
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
피험자 모집 중3상
- XCancer Omaha LLC, Omaha
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
피험자 모집 중1/2상
- Nebraska Cancer Specialists, Omaha
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
피험자 모집 중3상
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Integrated Cancer Repository for Cancer Research
피험자 모집 중관찰 연구건강한 지원자 환영
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- 외 1개
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
피험자 모집 중1상
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
피험자 모집 중4상
- Urology Cancer Center PC, Omaha
- Nebraska Cancer Specialists, Omaha
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
피험자 모집 중1/2상
- XCancer Omaha / Urology Cancer Center, Omaha
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
피험자 모집 중2상
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- 외 3개
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
피험자 모집 중3상
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9마일 거리
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
피험자 모집 중
- University of Nebraska Medical Center, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Omaha
다른 도시의 전립선암 시험
- New York City, NY연구 101개
- Houston, TX연구 73개
- Los Angeles, CA연구 64개
- Boston, MA연구 56개
- Seattle, WA연구 45개
- St. Louis, MO연구 45개
- Chicago, IL연구 45개
- Baltimore, MD연구 45개
- San Francisco, CA연구 44개
- Philadelphia, PA연구 41개
- Nashville, TN연구 40개
- Washington, DC연구 39개
Omaha의 다른 연구
- 비소세포폐암연구 25개
- 유방암연구 23개
- 암 (전체)연구 19개
- 대장직장암연구 18개
- 다발성 골수종연구 17개
- 난소암연구 15개
- 췌장암연구 15개
- 두경부 편평세포암연구 15개
- 전이성 암연구 14개
- 비호지킨 림프종연구 14개
- 폐암연구 13개
- 신장암 (신세포암)연구 12개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.